Loading clinical trials...
Loading clinical trials...
The Influence of Shade Guide Presentation Sequence and Psychosocial Factors on Patient Tooth Shade Selection: A Three-Arm Randomized Controlled Trial
This study is a clinical trial designed to understand how the way a dentist presents tooth color options affects a patient's final choice for their dental treatment. The insvestigators know that patients often prefer lighter, "bleached" shades, but the process of choosing can be influenced by the order in which the shades are shown. The insvestigators will randomly dividing participants into three groups. One group will see natural shades first, followed by bleached shades. A second group will see bleached shades first, followed by natural shades. The third group will see all shades at once. The main goal is to measure how often patients change their mind (switch their choice) and by how much (the "jump" in lightness) depending on the order of presentation. The insvestigators will also use a questionnaire to see if a patient's self-consciousness about their smile affects how light of a shade they choose. The results will help dentists improve communication and ensure patients are truly satisfied with their final aesthetic decision.
This is a prospective, single-center, three-arm parallel-group Randomized Controlled Trial (RCT) designed to rigorously investigate the cognitive bias known as the "order effect" in patient-driven tooth shade selection. The study aims to quantify the influence of sequential versus simultaneous shade guide presentation on final aesthetic preference and to correlate this choice with the patient's underlying psychosocial perception of their dental aesthetics. Methodology: Participants seeking aesthetic dental treatment will be randomized (1:1:1) into three intervention groups: 1. Group A (Natural -\> Bleached): Sequential presentation of natural shades followed by the introduction of bleached shades. 2. Group B (Bleached -\> Natural): Sequential presentation of bleached shades followed by the introduction of natural shades. 3. Group C (Simultaneous): Single presentation of the full VITA 3D-Master shade guide (natural and bleached tabs combined). Outcome Measures: The primary outcomes are the switching frequency and the magnitude of change (Delta L\*) between initial and final selections in the sequential groups (A and B), and the comparison of the final proportion of bleached shade selections across all three groups. Secondary outcomes include the correlation between the Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ) total score and the final selected shade's L\* value, and the quantification of the Patient-Clinician Discrepancy using CIE Delta E00 between the patient's choice and an independent clinician's recommendation. Significance: This study will provide evidence-based guidelines for clinical practice, moving beyond anecdotal preference recording to a structured, bias-mitigating approach to shared aesthetic decision-making. The integration of the PIDAQ and objective colorimetric analysis (Lab\*) and Delta E00 will provide a novel, high-impact explanation for the observed preference for lighter shades.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Univeristy of Jordan Hospital, Dental Department
Amman, Jordan
Start Date
January 26, 2026
Primary Completion Date
March 5, 2026
Completion Date
March 5, 2026
Last Updated
March 9, 2026
210
ACTUAL participants
Sequential Shade Presentation (Natural to Bleached)
BEHAVIORAL
Sequential Shade Presentation (Bleached to Natural)
BEHAVIORAL
Simultaneous Shade Presentation (Full Range)
BEHAVIORAL
Lead Sponsor
University of Jordan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04549935